Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Marvell Technology, Inc.MRVL · Entity 521 | Director | June 25, 2026 | June 29, 2026 |
| Nutanix, Inc.NTNX · Entity 3296 | Director · Chief Executive Officer | October 06, 2026 | October 08, 2026 |
| VMWARE LLCVMW · Entity 11690 | COO, Products & Cloud Services | November 24, 2020 | November 27, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Marvell Technology, Inc.
Report date June 25, 2026 · Filed June 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,082 |
Reported balance
After 2026-06-25 transaction · row 1
1 source rowRow 1 · 2026-06-25 · Exercise / conversion · Acquired 3,082 · Balance 3,082 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-06-25 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-25 · Exercise / conversion · Disposed 3,082 · Balance 0 F1: Each restricted stock unit represents a contingent right to receive one share of Common Stock of Marvell Technology, Inc. upon vesting. F2: Vested in full on June 25, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 1,034 |
Reported balance
After 2026-06-25 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-25 · Grant · Acquired 1,034 · Balance 1,034 F1: Each restricted stock unit represents a contingent right to receive one share of Common Stock of Marvell Technology, Inc. upon vesting. F3: Vests in full on the earlier of Marvell Technology, Inc.'s next annual meeting of stockholders or the one-year anniversary of the restricted stock unit grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of Common Stock of Marvell Technology, Inc. upon vesting.
F2: Vested in full on June 25, 2026.
F3: Vests in full on the earlier of Marvell Technology, Inc.'s next annual meeting of stockholders or the one-year anniversary of the restricted stock unit grant date.
Nutanix, Inc.
Report date October 06, 2026 · Filed October 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 634,849 |
Reported balance
After 2026-10-06 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-10-06 · Sale · Disposed 179,490 · Balance 634,849 F1: This transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 7, 2026. F2: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $72.70 to $73.695 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3: Includes 1 shares of Class A Common Stock acquired under the Nutanix, Inc. Employee Stock Purchase Plan on September 21, 2026. |
| Class A Common StockSEC Table I · non-derivative | Direct | 489,384 |
Reported balance
After 2026-10-06 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-10-06 · Sale · Disposed 145,465 · Balance 489,384 F1: This transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 7, 2026. F4: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $73.70 to $74.00 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| Class A Common StockSEC Table I · non-derivative | Direct | 414,339 |
Reported balance
After 2026-10-07 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-10-07 · Sale · Disposed 75,045 · Balance 414,339 F1: This transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 7, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 7, 2026.
F2: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $72.70 to $73.695 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: Includes 1 shares of Class A Common Stock acquired under the Nutanix, Inc. Employee Stock Purchase Plan on September 21, 2026.
F4: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $73.70 to $74.00 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
VMWARE LLC
Report date November 24, 2020 · Filed November 27, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 44,572 |
Reported balance
After 2020-11-24 transaction · row 1
1 source rowRow 1 · 2020-11-24 · Sale · Disposed 2,490 · Balance 44,572 |
| Class A Common StockSEC Table I · non-derivative | Indirectby GRAT | 30,500 |
Reported balance
Holding disclosure · report date 2020-11-24 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 30,500 |
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
NEOPHOTONICS CORP
Report date August 03, 2022 · Filed August 05, 2022
Section 16 reporting ended · disclosed 2022-08-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-08-03 transaction · row 1
1 source rowRow 1 · 2022-08-03 · Disposition to issuer · Disposed 49,459 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated November 3, 2021, by and among the Issuer, Lumentum Holdings Inc., a Delaware corporation ("Lumentum"), and Neptune Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Lumentum ("Merger Sub"), on August 3, 2022 (the "Closing Date"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Lumentum. In connection with the Merger, these shares were cancelled and converted into the right to receive $16.00 in cash, without interest, per share, subject to the terms and conditions of the Merger Agreement (the "Merger Consideration"). |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.25 | Direct | 0 |
Reported balance
After 2022-08-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-08-03 · Disposition to issuer · Disposed 7,692 · Balance 0 F2: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.33 | Direct | 0 |
Reported balance
After 2022-08-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-08-03 · Disposition to issuer · Disposed 14,056 · Balance 0 F2: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.78 | Direct | 0 |
Reported balance
After 2022-08-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-08-03 · Disposition to issuer · Disposed 12,486 · Balance 0 F2: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.56 | Direct | 0 |
Reported balance
After 2022-08-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-08-03 · Disposition to issuer · Disposed 8,960 · Balance 0 F2: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.68 | Direct | 0 |
Reported balance
After 2022-08-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2022-08-03 · Disposition to issuer · Disposed 2,880 · Balance 0 F2: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.20 | Direct | 0 |
Reported balance
After 2022-08-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2022-08-03 · Disposition to issuer · Disposed 7,521 · Balance 0 F2: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.41 | Direct | 0 |
Reported balance
After 2022-08-03 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2022-08-03 · Disposition to issuer · Disposed 2,656 · Balance 0 F2: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.17 | Direct | 0 |
Reported balance
After 2022-08-03 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2022-08-03 · Disposition to issuer · Disposed 7,641 · Balance 0 F2: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. |
| Restricted Stock Unit (right to acquire)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2022-08-03 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2022-08-03 · Disposition to issuer · Disposed 5,787 · Balance 0 F3: Restricted Stock Unit Awards of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated November 3, 2021, by and among the Issuer, Lumentum Holdings Inc., a Delaware corporation ("Lumentum"), and Neptune Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Lumentum ("Merger Sub"), on August 3, 2022 (the "Closing Date"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Lumentum. In connection with the Merger, these shares were cancelled and converted into the right to receive $16.00 in cash, without interest, per share, subject to the terms and conditions of the Merger Agreement (the "Merger Consideration").
F2: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option.
F3: Restricted Stock Unit Awards of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 20, 2022 Filed Sep 21, 2022 20:21 UTC | Nutanix, Inc. NTNX · Entity 3296 | SaleClass A Common Stock | 5,000 | $22.90 | $114,500.00 |
DisclosureSEC source: 0001209191-22-050910 · doc4.xml · nonDerivative · entry 1 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,576 F1 · shares: Shares sold pursuant to a 10b5-1 trading plan. F2 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.71 to $23.10 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 16, 2022 Filed Sep 19, 2022 22:12 UTC | Nutanix, Inc. NTNX · Entity 3296 | SaleClass A Common Stock | 65,376 | $22.93 | $1,499,071.68 |
DisclosureSEC source: 0001209191-22-050610 · doc4.xml · nonDerivative · entry 4 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,576 F1 · shares: Represents shares sold to cover the tax liability arising from the vesting of Reporting Person's Restricted Stock Units, or RSUs. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 22:12 UTC | Nutanix, Inc. NTNX · Entity 3296 | Exercise / conversionRestricted Stock Units · Derivative | 8,628 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-050610 · doc4.xml · derivative · entry 7 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,534 Underlying: Class A Common Stock · 8,628 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Class A common stock. F5 · derivative.exercise_date: The RSUs vest in 16 equal quarterly installments, with the first of such quarterly installments having vested on December 15, 2021, subject to the Reporting Person continuing to provide service to the Issuer through each vesting date. F5 · derivative.expiration_date: The RSUs vest in 16 equal quarterly installments, with the first of such quarterly installments having vested on December 15, 2021, subject to the Reporting Person continuing to provide service to the Issuer through each vesting date. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 22:12 UTC | Nutanix, Inc. NTNX · Entity 3296 | Exercise / conversionRestricted Stock Units · Derivative | 58,446 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-050610 · doc4.xml · derivative · entry 6 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 526,019 Underlying: Class A Common Stock · 58,446 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Class A common stock. F4 · derivative.exercise_date: As previously reported, on December 9, 2020, the Reporting Person was granted a target number of 703,117 performance-based RSUs ("PRSUs") subject to two stock price milestones. 133% of the target number of PRSUs became eligible to vest upon achievement of both milestones. The eligible PRSUs vested as to 25% of the underlying shares on December 15, 2021, with 1/16th of the remaining shares vesting quarterly thereafter, subject to the Reporting Person continuing to provide service to the Issuer through each vesting date. F4 · derivative.expiration_date: As previously reported, on December 9, 2020, the Reporting Person was granted a target number of 703,117 performance-based RSUs ("PRSUs") subject to two stock price milestones. 133% of the target number of PRSUs became eligible to vest upon achievement of both milestones. The eligible PRSUs vested as to 25% of the underlying shares on December 15, 2021, with 1/16th of the remaining shares vesting quarterly thereafter, subject to the Reporting Person continuing to provide service to the Issuer through each vesting date. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 22:12 UTC | Nutanix, Inc. NTNX · Entity 3296 | Exercise / conversionRestricted Stock Units · Derivative | 23,662 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-050610 · doc4.xml · derivative · entry 5 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 212,964 Underlying: Class A Common Stock · 23,662 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Class A common stock. F3 · derivative.exercise_date: The RSUs vested as to 25% of the underlying shares on December 15, 2021, with 1/16th of the remaining shares vesting quarterly thereafter subject to the Reporting Person continuing to provide service to the Issuer through each vesting date. F3 · derivative.expiration_date: The RSUs vested as to 25% of the underlying shares on December 15, 2021, with 1/16th of the remaining shares vesting quarterly thereafter subject to the Reporting Person continuing to provide service to the Issuer through each vesting date. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 22:12 UTC | Nutanix, Inc. NTNX · Entity 3296 | Exercise / conversionClass A Common Stock | 8,628 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-050610 · doc4.xml · nonDerivative · entry 3 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 337,952 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 22:12 UTC | Nutanix, Inc. NTNX · Entity 3296 | Exercise / conversionClass A Common Stock | 58,446 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-050610 · doc4.xml · nonDerivative · entry 2 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329,324 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 22:12 UTC | Nutanix, Inc. NTNX · Entity 3296 | Exercise / conversionClass A Common Stock | 23,662 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-050610 · doc4.xml · nonDerivative · entry 1 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,878 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 25, 2022 Filed Aug 29, 2022 20:15 UTC | Nutanix, Inc. NTNX · Entity 3296 | GrantRestricted Stock Units · Derivative | 275,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-047844 · doc4.xml · derivative · entry 2 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,302 Underlying: Class A Common Stock · 275,302 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit, or RSU, represents a contingent right to receive one share of Issuer's Class A common stock. F3 · derivative.exercise_date: The RSUs will vest in 16 equal quarterly installments, with the first of such quarterly installments to vest on December 15, 2022, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date. F3 · derivative.expiration_date: The RSUs will vest in 16 equal quarterly installments, with the first of such quarterly installments to vest on December 15, 2022, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date. Read SEC document |
| August 25, 2022 Filed Aug 29, 2022 20:15 UTC | Nutanix, Inc. NTNX · Entity 3296 | GrantClass A Common Stock | 28,824 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-047844 · doc4.xml · nonDerivative · entry 1 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,216 F1 · shares: On October 11, 2021, the Reporting Person was granted performance-based restricted stock units ("PRSUs"). The PRSUs are eligible to vest in up to three installments based on the total shareholder return of the Issuer over one-, two- and three-year performance periods, each commencing on August 1, 2021, relative to the total shareholder return of companies in the NASDAQ Composite Index. On August 25, 2022, the Compensation Committee of the Issuer's Board of Directors determined that the achievement percentage for the first performance period was 62.6385%, resulting in these shares becoming eligible to vest on September 15, 2022, subject to the Reporting Person continuing to provide service to the Issuer through the vesting date. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 21:38 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | Disposition to issuerRestricted Stock Unit (right to acquire) · Derivative | 5,787 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001209191-22-044613 · doc4.xml · derivative · entry 10 RAMASWAMI RAJIV · CIK 0001483009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,787 shares Expires not disclosed F3 · price: Restricted Stock Unit Awards of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration. F3 · derivative.exercise_date: Restricted Stock Unit Awards of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration. F3 · derivative.expiration_date: Restricted Stock Unit Awards of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 21:38 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 7,641 | Not disclosed Strike: $10.17 | Not disclosed |
DisclosureSEC source: 0001209191-22-044613 · doc4.xml · derivative · entry 9 RAMASWAMI RAJIV · CIK 0001483009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,641 shares Expires not disclosed F2 · price: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. F2 · derivative.exercise_date: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. F2 · derivative.expiration_date: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 21:38 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 2,656 | Not disclosed Strike: $9.41 | Not disclosed |
DisclosureSEC source: 0001209191-22-044613 · doc4.xml · derivative · entry 8 RAMASWAMI RAJIV · CIK 0001483009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,656 shares Expires not disclosed F2 · price: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. F2 · derivative.exercise_date: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. F2 · derivative.expiration_date: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 21:38 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 7,521 | Not disclosed Strike: $9.20 | Not disclosed |
DisclosureSEC source: 0001209191-22-044613 · doc4.xml · derivative · entry 7 RAMASWAMI RAJIV · CIK 0001483009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,521 shares Expires not disclosed F2 · price: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. F2 · derivative.exercise_date: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. F2 · derivative.expiration_date: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 21:38 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 2,880 | Not disclosed Strike: $8.68 | Not disclosed |
DisclosureSEC source: 0001209191-22-044613 · doc4.xml · derivative · entry 6 RAMASWAMI RAJIV · CIK 0001483009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,880 shares Expires not disclosed F2 · price: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. F2 · derivative.exercise_date: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. F2 · derivative.expiration_date: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 21:38 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 8,960 | Not disclosed Strike: $8.56 | Not disclosed |
DisclosureSEC source: 0001209191-22-044613 · doc4.xml · derivative · entry 5 RAMASWAMI RAJIV · CIK 0001483009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,960 shares Expires not disclosed F2 · price: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. F2 · derivative.exercise_date: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. F2 · derivative.expiration_date: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 21:38 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 12,486 | Not disclosed Strike: $6.78 | Not disclosed |
DisclosureSEC source: 0001209191-22-044613 · doc4.xml · derivative · entry 4 RAMASWAMI RAJIV · CIK 0001483009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,486 shares Expires not disclosed F2 · price: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. F2 · derivative.exercise_date: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. F2 · derivative.expiration_date: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 21:38 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 14,056 | Not disclosed Strike: $4.33 | Not disclosed |
DisclosureSEC source: 0001209191-22-044613 · doc4.xml · derivative · entry 3 RAMASWAMI RAJIV · CIK 0001483009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,056 shares Expires not disclosed F2 · price: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. F2 · derivative.exercise_date: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. F2 · derivative.expiration_date: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 21:38 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 7,692 | Not disclosed Strike: $3.25 | Not disclosed |
DisclosureSEC source: 0001209191-22-044613 · doc4.xml · derivative · entry 2 RAMASWAMI RAJIV · CIK 0001483009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,692 shares Expires not disclosed F2 · price: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. F2 · derivative.exercise_date: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. F2 · derivative.expiration_date: Options to purchase common stock of the Issuer, whether vested or unvested as of immediately prior to the Closing Date, were cancelled and converted into the right to receive the Merger Consideration, less the exercise price per share of such cancelled option. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 21:38 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | Disposition to issuerCommon Stock | 49,459 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-044613 · doc4.xml · nonDerivative · entry 1 RAMASWAMI RAJIV · CIK 0001483009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated November 3, 2021, by and among the Issuer, Lumentum Holdings Inc., a Delaware corporation ("Lumentum"), and Neptune Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Lumentum ("Merger Sub"), on August 3, 2022 (the "Closing Date"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Lumentum. In connection with the Merger, these shares were cancelled and converted into the right to receive $16.00 in cash, without interest, per share, subject to the terms and conditions of the Merger Agreement (the "Merger Consideration"). F1 · price: Pursuant to the Agreement and Plan of Merger (the "Merger Agreement") dated November 3, 2021, by and among the Issuer, Lumentum Holdings Inc., a Delaware corporation ("Lumentum"), and Neptune Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Lumentum ("Merger Sub"), on August 3, 2022 (the "Closing Date"), Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Lumentum. In connection with the Merger, these shares were cancelled and converted into the right to receive $16.00 in cash, without interest, per share, subject to the terms and conditions of the Merger Agreement (the "Merger Consideration"). Read SEC document |
| June 21, 2022 Filed Jun 22, 2022 20:05 UTC | Nutanix, Inc. NTNX · Entity 3296 | SaleClass A Common Stock | 5,000 | $14.62 | $73,080.50 |
DisclosureSEC source: 0001209191-22-038663 · doc4.xml · nonDerivative · entry 1 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 218,392 F1 · shares: Shares sold pursuant to a 10b5-1 trading plan. F2 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $14.46 to $14.90 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 22:50 UTC | Nutanix, Inc. NTNX · Entity 3296 | SaleClass A Common Stock | 50,134 | $13.97 | $700,371.98 |
DisclosureSEC source: 0001209191-22-038125 · doc4.xml · nonDerivative · entry 4 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,392 F1 · shares: Represents shares sold to cover the tax liability arising from the vesting of Reporting Person's Restricted Stock Units, or RSUs. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:50 UTC | Nutanix, Inc. NTNX · Entity 3296 | Exercise / conversionRestricted Stock Units · Derivative | 8,628 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-038125 · doc4.xml · derivative · entry 7 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,162 Underlying: Class A Common Stock · 8,628 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Class A common stock. F5 · derivative.exercise_date: The RSUs vest in 16 equal quarterly installments, with the first of such quarterly installments having vested on December 15, 2021, subject to the Reporting Person continuing to provide service to the Issuer through each vesting date. F5 · derivative.expiration_date: The RSUs vest in 16 equal quarterly installments, with the first of such quarterly installments having vested on December 15, 2021, subject to the Reporting Person continuing to provide service to the Issuer through each vesting date. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:50 UTC | Nutanix, Inc. NTNX · Entity 3296 | Exercise / conversionRestricted Stock Units · Derivative | 58,447 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-038125 · doc4.xml · derivative · entry 6 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 584,465 Underlying: Class A Common Stock · 58,447 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Class A common stock. F4 · derivative.exercise_date: As previously reported, on December 9, 2020, the Reporting Person was granted a target number of 703,117 performance-based RSUs ("PRSUs") subject to two stock price milestones. 133% of the target number of PRSUs became eligible to vest upon achievement of both milestones. The eligible PRSUs vested as to 25% of the underlying shares on December 15, 2021, with 1/16th of the remaining shares vesting quarterly thereafter, subject to the Reporting Person continuing to provide service to the Issuer through each vesting date. F4 · derivative.expiration_date: As previously reported, on December 9, 2020, the Reporting Person was granted a target number of 703,117 performance-based RSUs ("PRSUs") subject to two stock price milestones. 133% of the target number of PRSUs became eligible to vest upon achievement of both milestones. The eligible PRSUs vested as to 25% of the underlying shares on December 15, 2021, with 1/16th of the remaining shares vesting quarterly thereafter, subject to the Reporting Person continuing to provide service to the Issuer through each vesting date. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:50 UTC | Nutanix, Inc. NTNX · Entity 3296 | Exercise / conversionRestricted Stock Units · Derivative | 23,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-038125 · doc4.xml · derivative · entry 5 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,626 Underlying: Class A Common Stock · 23,663 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Class A common stock. F3 · derivative.exercise_date: The RSUs vested as to 25% of the underlying shares on December 15, 2021, with 1/16th of the remaining shares vesting quarterly thereafter subject to the Reporting Person continuing to provide service to the Issuer through each vesting date. F3 · derivative.expiration_date: The RSUs vested as to 25% of the underlying shares on December 15, 2021, with 1/16th of the remaining shares vesting quarterly thereafter subject to the Reporting Person continuing to provide service to the Issuer through each vesting date. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:50 UTC | Nutanix, Inc. NTNX · Entity 3296 | Exercise / conversionClass A Common Stock | 8,628 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-038125 · doc4.xml · nonDerivative · entry 3 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 273,526 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:50 UTC | Nutanix, Inc. NTNX · Entity 3296 | Exercise / conversionClass A Common Stock | 58,447 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-038125 · doc4.xml · nonDerivative · entry 2 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,898 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 22:50 UTC | Nutanix, Inc. NTNX · Entity 3296 | Exercise / conversionClass A Common Stock | 23,663 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-038125 · doc4.xml · nonDerivative · entry 1 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 22:10 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | GrantRestricted Stock Units (right to acquire) · Derivative | 5,787 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001227025-22-000073 · edgardoc.xml · derivative · entry 3 RAMASWAMI RAJIV · CIK 0001483009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,787 Underlying: Common Stock · 5,787 shares Expires 2023-06-02 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of NeoPhotonics common stock. F2 · derivative.exercise_date: This RSU shall vest on the 12 month anniversary of the grant date, so long as the Reporting Person remains a member of the Board of Directors of the Company. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 22:10 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | Exercise / conversionRestricted Stock Units (right to acquire) · Derivative | 4,621 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001227025-22-000073 · edgardoc.xml · derivative · entry 2 RAMASWAMI RAJIV · CIK 0001483009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,621 shares Expires 2022-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of NeoPhotonics common stock. F2 · derivative.exercise_date: This RSU shall vest on the 12 month anniversary of the grant date, so long as the Reporting Person remains a member of the Board of Directors of the Company. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 22:10 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | Exercise / conversionCommon Stock | 4,621 | $0.00 | $0.00 |
DisclosureSEC source: 0001227025-22-000073 · edgardoc.xml · nonDerivative · entry 1 RAMASWAMI RAJIV · CIK 0001483009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,459 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 18, 2022 Filed Mar 22, 2022 00:21 UTC | Nutanix, Inc. NTNX · Entity 3296 | SaleClass A Common Stock | 5,000 | $24.72 | $123,583.50 |
DisclosureSEC source: 0001209191-22-020408 · doc4.xml · nonDerivative · entry 1 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,788 F1 · shares: Shares sold pursuant to the Reporting Persons 10b5-1 trading plan. F2 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $24.55 to $24.915 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes 953 shares of Class A Common Stock acquired under the Nutanix, Inc. Employee Stock Purchase Plan on March 20, 2022. Read SEC document |
| March 16, 2022 Filed Mar 17, 2022 23:02 UTC | Nutanix, Inc. NTNX · Entity 3296 | SaleClass A Common Stock | 46,233 | $23.78 | $1,099,420.74 |
DisclosureSEC source: 0001209191-22-019782 · doc4.xml · nonDerivative · entry 4 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,835 F1 · shares: Represents shares sold to cover the tax liability arising from the vesting of Reporting Person's Restricted Stock Units, or RSUs. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 23:02 UTC | Nutanix, Inc. NTNX · Entity 3296 | Exercise / conversionRestricted Stock Units · Derivative | 8,628 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-019782 · doc4.xml · derivative · entry 7 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,790 Underlying: Class A Common Stock · 8,628 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Class A common stock. F5 · derivative.exercise_date: The RSUs vest in 16 equal quarterly installments, with the first of such quarterly installments having vested on December 15, 2021, subject to the Reporting Person continuing to provide service to the Issuer through each vesting date. F5 · derivative.expiration_date: The RSUs vest in 16 equal quarterly installments, with the first of such quarterly installments having vested on December 15, 2021, subject to the Reporting Person continuing to provide service to the Issuer through each vesting date. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 23:02 UTC | Nutanix, Inc. NTNX · Entity 3296 | Exercise / conversionRestricted Stock Units · Derivative | 58,447 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-019782 · doc4.xml · derivative · entry 6 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 642,912 Underlying: Class A Common Stock · 58,447 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Class A common stock. F4 · derivative.exercise_date: As previously reported, on December 9, 2020, the Reporting Person was granted a target number of 703,117 performance-based RSUs ("PRSUs") subject to two stock price milestones. 133% of the target number of PRSUs became eligible to vest upon achievement of both milestones. The eligible PRSUs vested as to 25% of the underlying shares on December 15, 2021, with 1/16th of the remaining shares vesting quarterly thereafter, subject to the Reporting Person continuing to provide service to the Issuer through each vesting date. F4 · derivative.expiration_date: As previously reported, on December 9, 2020, the Reporting Person was granted a target number of 703,117 performance-based RSUs ("PRSUs") subject to two stock price milestones. 133% of the target number of PRSUs became eligible to vest upon achievement of both milestones. The eligible PRSUs vested as to 25% of the underlying shares on December 15, 2021, with 1/16th of the remaining shares vesting quarterly thereafter, subject to the Reporting Person continuing to provide service to the Issuer through each vesting date. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 23:02 UTC | Nutanix, Inc. NTNX · Entity 3296 | Exercise / conversionRestricted Stock Units · Derivative | 23,662 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-019782 · doc4.xml · derivative · entry 5 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,289 Underlying: Class A Common Stock · 23,662 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Class A common stock. F3 · derivative.exercise_date: The RSUs vested as to 25% of the underlying shares on December 15, 2021, with 1/16th of the remaining shares vesting quarterly thereafter subject to the Reporting Person continuing to provide service to the Issuer through each vesting date. F3 · derivative.expiration_date: The RSUs vested as to 25% of the underlying shares on December 15, 2021, with 1/16th of the remaining shares vesting quarterly thereafter subject to the Reporting Person continuing to provide service to the Issuer through each vesting date. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 23:02 UTC | Nutanix, Inc. NTNX · Entity 3296 | Exercise / conversionClass A Common Stock | 8,628 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-019782 · doc4.xml · nonDerivative · entry 3 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,068 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 23:02 UTC | Nutanix, Inc. NTNX · Entity 3296 | Exercise / conversionClass A Common Stock | 58,447 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-019782 · doc4.xml · nonDerivative · entry 2 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224,440 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2022 Filed Mar 17, 2022 23:02 UTC | Nutanix, Inc. NTNX · Entity 3296 | Exercise / conversionClass A Common Stock | 23,662 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-019782 · doc4.xml · nonDerivative · entry 1 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,993 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 19:32 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 4,400 | $0.00 Strike: $4.50 | $0.00 |
DisclosureSEC source: 0001227025-22-000018 · edgardoc.xml · derivative · entry 2 RAMASWAMI RAJIV · CIK 0001483009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,400 shares Expires 2022-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted to Dr. Ramaswami during his tenure on the Company's technical advisory board and prior to his appointment to the Board of Directors. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 19:32 UTC | NEOPHOTONICS CORP NPTN · Entity 124843 | Exercise / conversionCommon Stock | 4,400 | $4.50 | $19,800.00 |
DisclosureSEC source: 0001227025-22-000018 · edgardoc.xml · nonDerivative · entry 1 RAMASWAMI RAJIV · CIK 0001483009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,838 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents a cash exercise. Read SEC document |
| December 21, 2021 Filed Dec 22, 2021 22:21 UTC | Nutanix, Inc. NTNX · Entity 3296 | SaleClass A Common Stock | 5,000 | $30.64 | $153,201.00 |
DisclosureSEC source: 0001209191-21-070965 · doc4.xml · nonDerivative · entry 1 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,331 F1 · kind: Shares sold pursuant to a 10b5-1 trading plan entered into by the Reporting Person. F2 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $30.26 to $31.00 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 16, 2021 Filed Dec 21, 2021 02:02 UTC | Nutanix, Inc. NTNX · Entity 3296 | SaleClass A Common Stock | 190,685 | $30.39 | $5,794,230.68 |
DisclosureSEC source: 0001209191-21-070717 · doc4.xml · nonDerivative · entry 1 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,331 F1 · shares: Represents shares sold to cover the tax liability arising from the vesting of Reporting Person's Restricted Stock Units, or RSUs. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 23:05 UTC | Nutanix, Inc. NTNX · Entity 3296 | Exercise / conversionRestricted Stock Units · Derivative | 8,627 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-070403 · doc4.xml · derivative · entry 6 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 129,418 Underlying: Class A Common Stock · 8,627 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit, or RSU, represents a contingent right to receive one share of the Issuer's Class A common stock. F5 · derivative.exercise_date: The RSUs vest in 16 equal quarterly installments, with the first of such quarterly installments having vested on December 15, 2021, subject to the Reporting Person continuing to provide service to the Issuer through each vesting date. F5 · derivative.expiration_date: The RSUs vest in 16 equal quarterly installments, with the first of such quarterly installments having vested on December 15, 2021, subject to the Reporting Person continuing to provide service to the Issuer through each vesting date. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 23:05 UTC | Nutanix, Inc. NTNX · Entity 3296 | Exercise / conversionRestricted Stock Units · Derivative | 233,786 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-070403 · doc4.xml · derivative · entry 5 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 701,359 Underlying: Class A Common Stock · 233,786 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit, or RSU, represents a contingent right to receive one share of the Issuer's Class A common stock. F4 · derivative.exercise_date: As previously reported, on December 9, 2020, the Reporting Person was granted a target number of 703,117 performance-based RSUs ("PRSUs") subject to two stock price milestones. 133% of the target number of PRSUs became eligible to vest upon achievement of both milestones. The eligible PRSUs vested as to 25% of the underlying shares on December 15, 2021, with 1/16th of the remaining shares to vest quarterly thereafter, subject to the Reporting Person continuing to provide service to the Issuer through each vesting date. F4 · derivative.expiration_date: As previously reported, on December 9, 2020, the Reporting Person was granted a target number of 703,117 performance-based RSUs ("PRSUs") subject to two stock price milestones. 133% of the target number of PRSUs became eligible to vest upon achievement of both milestones. The eligible PRSUs vested as to 25% of the underlying shares on December 15, 2021, with 1/16th of the remaining shares to vest quarterly thereafter, subject to the Reporting Person continuing to provide service to the Issuer through each vesting date. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 23:05 UTC | Nutanix, Inc. NTNX · Entity 3296 | Exercise / conversionRestricted Stock Units · Derivative | 94,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-070403 · doc4.xml · derivative · entry 4 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,951 Underlying: Class A Common Stock · 94,650 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit, or RSU, represents a contingent right to receive one share of the Issuer's Class A common stock. F3 · derivative.exercise_date: The RSUs vested as to 25% of the underlying shares on December 15, 2021, with 1/16th of the remaining shares to vest quarterly thereafter subject to the Reporting Person continuing to provide service to the Issuer through each vesting date. F3 · derivative.expiration_date: The RSUs vested as to 25% of the underlying shares on December 15, 2021, with 1/16th of the remaining shares to vest quarterly thereafter subject to the Reporting Person continuing to provide service to the Issuer through each vesting date. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 23:05 UTC | Nutanix, Inc. NTNX · Entity 3296 | Exercise / conversionClass A Common Stock | 8,627 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-070403 · doc4.xml · nonDerivative · entry 3 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 23:05 UTC | Nutanix, Inc. NTNX · Entity 3296 | Exercise / conversionClass A Common Stock | 233,786 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-070403 · doc4.xml · nonDerivative · entry 2 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329,389 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 23:05 UTC | Nutanix, Inc. NTNX · Entity 3296 | Exercise / conversionClass A Common Stock | 94,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-070403 · doc4.xml · nonDerivative · entry 1 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,603 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired under the Nutanix, Inc. Employee Stock Purchase Plan on September 20, 2021. Read SEC document |
| October 11, 2021 Filed Oct 13, 2021 20:57 UTC | Nutanix, Inc. NTNX · Entity 3296 | GrantRestricted Stock Units · Derivative | 138,045 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-060379 · doc4.xml · derivative · entry 1 RAMASWAMI RAJIV · CIK 0001483009 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,045 Underlying: Class A Common Stock · 138,045 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit, or RSU, represents a contingent right to receive one share of Issuer's Class A common stock. F2 · derivative.exercise_date: The RSUs will vest in 16 equal quarterly installments, with the first of such quarterly installments to vest on December 15, 2021, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date. F2 · derivative.expiration_date: The RSUs will vest in 16 equal quarterly installments, with the first of such quarterly installments to vest on December 15, 2021, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.